U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose

obesity overweight weight diet

Key Takeaways

  • For the first time in a decade, the obesity rate for adult Americans charted a slight decline in 2023

  • The trend follows the rising use of GLP-1 weight-loss medications such as Zepbound or Wegovy

  • Declines in obesity were sharpest in the South and among older Americans

Recommended for you

Originally published on healthday.com, part of the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Please log in, or sign up for a new, free account to read or post comments.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.